Literature DB >> 17207030

Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa.

Sheng-Hsiang Lin1, Ping-Hung Kuo, Po-Ren Hsueh, Pan-Chyr Yang, Sow-Hsong Kuo.   

Abstract

BACKGROUND AND
OBJECTIVE: Bacterial infection is one of the major causes of acute exacerbation of COPD (AECOPD). This study was undertaken to investigate the microbiology of AECOPD.
METHODS: Medical records from 494 episodes of AECOPD in patients admitted to the National Taiwan University Hospital from January 2000 to June 2004 were reviewed. Severity of COPD was classified according to the 2003 Global Initiative for Chronic Obstructive Lung Disease guideline.
RESULTS: Potential pathogenic microorganisms were isolated from patients in 328 (66.4%) episodes of AECOPD. The predominant bacteria were Klebsiella pneumoniae (19.6%), Pseudomonas aeruginosa (16.8%) and Haemophilus influenzae (7.5%), followed by Acinetobacter baumannii (6.9%), Enterobacter species (6.1%) and Staphylococcus aureus (6.1%). The incidence of Streptococcus pneumoniae was 2.4%. Spirometry results obtained within 1 year of the exacerbation were available in 186 cases. K. pneumoniae was more frequently isolated in stage I COPD (39.1%) than stage II (16.6%), III (13.8%) and IV (9.4%). No glucose non-fermentative Gram-negative bacilli were isolated in stage I patients. Multivariate logistic regression analysis revealed that P. aeruginosa (odds ratio (OR) 3.19; 95% confidence interval (CI): 1.21-8.38), intubation (OR 14.81; 95% CI: 5.08-43.12) and age (OR 1.1; 95% CI: 1.03-1.17) were independent risk factors for mortality.
CONCLUSIONS: Klebsiella pneumoniae and P. aeruginosa are the most common sputum pathogens in hospitalized patients with AECOPD in Taiwan, with the former being more commonly isolated from mild COPD and the latter associated with poor clinical outcome. These results should be considered when deciding which antibiotics should initially be used to treat patients with AECOPD.

Entities:  

Mesh:

Year:  2007        PMID: 17207030     DOI: 10.1111/j.1440-1843.2006.00999.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  18 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

Authors:  Ashok Kuwal; Vinod Joshi; Naveen Dutt; Surjit Singh; Kailash Chand Agarwal; Gopal Purohit
Journal:  Turk Thorac J       Date:  2017-11-29

3.  N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.

Authors:  Tiemei Zhao; Youning Liu
Journal:  BMC Microbiol       Date:  2010-05-12       Impact factor: 3.605

4.  Predicting Healthcare Utilization by Patients Admitted for COPD Exacerbation.

Authors:  Karthikeyan Ramaraju; Anupama Murthy Kaza; Nithilavalli Balasubramanian; Siddhuraj Chandrasekaran
Journal:  J Clin Diagn Res       Date:  2016-02-01

5.  Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.

Authors:  Chih-Hao Chang; Kuo-Chien Tsao; Han-Chung Hu; Chung-Chi Huang; Kuo-Chin Kao; Ning-Hung Chen; Cheng-Ta Yang; Ying-Huang Tsai; Meng-Jer Hsieh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-13

6.  Bufei Jianpi granules improve skeletal muscle and mitochondrial dysfunction in rats with chronic obstructive pulmonary disease.

Authors:  Yuqiong Dong; Ya Li; Yafei Sun; Jing Mao; Fengjia Yao; Yange Tian; Lili Wang; Linlin Li; Suyun Li; Jiansheng Li
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

7.  Multidrug resistant Gram-negative bacilli in lower respiratory tract infections.

Authors:  Shashidhar Vishwanath; Kiran Chawla; Anusha Gopinathan
Journal:  Iran J Microbiol       Date:  2013-12

8.  Assessment of some inflammatory biomarkers as predictors of outcome of acute respiratory failure on top of chronic obstructive pulmonary disease and evaluation of the role of bacteria.

Authors:  Hanaa Ahmed Shafiek; Nashwa Hassan Abd-Elwahab; Manal Mohammad Baddour; Mohamed Mabrouk El-Hoffy; Akram Abd-Elmoneim Degady; Yehia Mohamed Khalil
Journal:  ISRN Microbiol       Date:  2012-06-21

9.  Fluoroquinolones versus β-Lactam/β-Lactamase Inhibitors in Outpatients with Chronic Obstructive Pulmonary Disease and Pneumonia: A Nationwide Population-Based Study.

Authors:  Kuan-Yin Lin; Chi-Chuan Wang; Chia-Hui Lin; Wang-Huei Sheng; Shan-Chwen Chang
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

10.  Does a single Pseudomonas aeruginosa isolation predict COPD mortality?

Authors:  Afroditi K Boutou; Yogini Raste; Jeremy Reid; Khalid Alshafi; Michael I Polkey; Nicholas S Hopkinson
Journal:  Eur Respir J       Date:  2014-07-17       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.